Gender

Visit number vs Reactive hyperemia index: EndoPAT2000
N Mean StdDev Median Min Max Unknown Total
Baseline 313 2.0 ± 0.5 1.9 1.0 4.2 5 318
Follow-up 292 2.1 ± 0.6 2.0 1.0 5.8 9 301
Treatment Arm vs Reactive hyperemia index: EndoPAT2000
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 313 2.0 ± 0.5 1.9 1.0 4.2 5 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 105 2.1 ± 0.6 1.9 1.2 4.2 1 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 102 1.9 ± 0.4 1.8 1.2 3.4 4 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 2.0 ± 0.5 1.9 1.0 3.4 - 106
Treatment Arm vs Reactive hyperemia index: EndoPAT2000
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 292 2.1 ± 0.6 2.0 1.0 5.8 9 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 97 2.2 ± 0.7 2.1 1.2 5.8 3 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 97 2.0 ± 0.6 1.9 1.0 3.9 4 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 98 2.0 ± 0.5 2.0 1.1 3.3 2 100
Age category vs Reactive hyperemia index: EndoPAT2000
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 313 2.0 ± 0.5 1.9 1.0 4.2 5 318
45-54 years 53 2.0 ± 0.5 1.9 1.0 3.1 - 53
55-64 years 138 2.0 ± 0.5 1.8 1.1 4.2 1 139
65 years or older 122 2.0 ± 0.6 1.9 1.2 4.0 4 126
Age category vs Reactive hyperemia index: EndoPAT2000
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 292 2.1 ± 0.6 2.0 1.0 5.8 8 300
45-54 years 48 2.0 ± 0.5 1.9 1.2 3.3 1 49
55-64 years 124 2.0 ± 0.5 1.9 1.2 3.9 3 127
65 years or older 120 2.2 ± 0.7 2.1 1.0 5.8 4 124
Gender of the participant vs Reactive hyperemia index: EndoPAT2000
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 313 2.0 ± 0.5 1.9 1.0 4.2 5 318
Female 83 2.2 ± 0.6 2.1 1.1 3.7 1 84
Male 230 1.9 ± 0.5 1.8 1.0 4.2 4 234
Gender of the participant vs Reactive hyperemia index: EndoPAT2000
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 292 2.1 ± 0.6 2.0 1.0 5.8 9 301
Female 77 2.2 ± 0.7 2.2 1.0 4.1 2 79
Male 215 2.0 ± 0.6 1.9 1.1 5.8 7 222
Race of the participant vs Reactive hyperemia index: EndoPAT2000
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 312 2.0 ± 0.5 1.9 1.0 4.2 5 317
White 253 2.0 ± 0.5 1.9 1.1 4.2 3 256
American Indian or Alaskan Native 2 2.0 ± 0.6 2.0 1.5 2.4 - 2
Black or African American 41 2.1 ± 0.6 2.1 1.0 3.4 2 43
Asian 6 2.2 ± 0.5 1.9 1.7 2.9 - 6
Native Hawaiian or other Pacific islander 1 3.7 - 3.7 3.7 3.7 - 1
Other 4 1.9 ± 0.3 1.9 1.5 2.2 - 4
Multiple 5 1.8 ± 0.6 1.6 1.3 2.7 - 5
Race of the participant vs Reactive hyperemia index: EndoPAT2000
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 291 2.1 ± 0.6 2.0 1.0 5.8 8 299
White 236 2.1 ± 0.6 2.0 1.1 5.8 5 241
American Indian or Alaskan Native 2 1.4 ± 0.04 1.4 1.4 1.4 - 2
Black or African American 38 2.1 ± 0.5 2.2 1.0 3.1 3 41
Asian 6 2.2 ± 0.5 2.2 1.5 2.9 - 6
Native Hawaiian or other Pacific islander 1 3.1 - 3.1 3.1 3.1 - 1
Other 3 2.6 ± 0.8 3.0 1.7 3.2 - 3
Multiple 5 1.7 ± 0.4 1.4 1.3 2.2 - 5